Inovio Pharmaceuticals, Inc. (INO) is a publicly traded Healthcare sector company. As of October 6, 2026, INO trades at $1.14 with a market cap of $118.91M and a P/E ratio of -0.66. INO moved -2.61% today. Year to date, INO is -33.14%; over the trailing twelve months it is -53.11%. Its 52-week range spans $0.56 to $2.98. Analyst consensus is buy with an average price target of $3.17. Rallies surfaces INO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks INO insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.14 |
| Market Cap | $118.91M |
| P/E Ratio | -0.66 |
| EPS | $-1.81 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.98 |
| 52-Week Low | $0.56 |
| Volume | 1.96M |
| Avg Volume | 0 |
| Revenue (TTM) | $65.34K |
| Net Income | $-84.95M |
| Gross Margin | 0.00% |
3 analysts cover INO: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.17.